
Britain Authorizes Merck Antiviral Pill, First Shown to Treat COVID
By MATTHEW PERRONE and MARIA CHENG, The Associated Press
LONDON (AP) — Britain has granted a conditional authorization to Merck's coronavirus antiviral. It's the first pill shown to successfully treat COVID-19.
The U.K. is the first country to OK the treatment. But it wasn't immediately clear how quickly the drug known as molnupiravir will be available. It's intended to be taken at home twice a day for five days by people with mild to moderate COVID-19.
An antiviral pill that reduces symptoms and speeds recovery could prove groundbreaking, easing caseloads on hospitals and helping to curb outbreaks in poorer countries with fragile health systems.
Molnupiravir is also pending review by regulators in the United States and the European Union.
Utica's Chicken Riggies Dish Wasn't Invented in Utica? Say It Isn't So.
Gallery Credit: Bill Keeler
Demystifying the Funeral Home Prep Room
Gallery Credit: Kristine Bellino
11 Ways to Avoid Getting Ripped Off When Holiday Shopping Online
Gallery Credit: Bill Keeler
More From WIBX 950








